Statin and aspirin for prevention of hepatocellular carcinoma: What are the levels of evidence?

被引：18

作者：

Carrat, Fabrice ^{[1
,2
]}

机构：

[1] INSERM, UMR S 1136, Paris, France

[2] St Antoine Hosp, AP HP, Dept Publ Hlth, Paris, France

来源：

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2014年 / 38卷 / 01期

关键词：

HEPATITIS-B-VIRUS; LOW-DOSE ASPIRIN; CANCER-RISK; COLORECTAL-CANCER; FOLLOW-UP;

D O I：

10.1016/j.clinre.2013.09.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Recent analyses of large cohorts suggest that statins or aspirin may reduce the risk of hepatocellular carcinoma (HCC). Due to their observational nature, these studies may have been flawed by confounding by indication or immortal time bias. Reviews of clinical trials conducted in the metabolic or cardiovascular domain showed no effect of statins on cancer of any type, but identified a 20% reduction of cancer with aspirin use. The effect of aspirin was concentrated to adenocarcinomas. More convincing evidence is needed to support the potential preventive effect of aspirin on HCC, but a clinical trial would be achievable in patients who are at high risk. (C) 2013 Elsevier Masson SAS. All rights reserved.

引用

页码：9 / 11

页数：3

共 17 条

[1]

BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO

[2]

2-J

[3] Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial [J].

Burn, John ;

Gerdes, Anne-Marie ;

Macrae, Finlay ;

Mecklin, Jukka-Pekka ;

Moeslein, Gabriela ;

Olschwang, Sylviane ;

Eccles, Diane ;

Evans, D. Gareth ;

Maher, Eamonn R. ;

Bertario, Lucio ;

Bisgaard, Marie-Luise ;

Dunlop, Malcolm G. ;

Ho, Judy W. C. ;

Hodgson, Shirley V. ;

Lindblom, Annika ;

Lubinski, Jan ;

Morrison, Patrick J. ;

Murday, Victoria ;

Ramesar, Raj ;

Side, Lucy ;

Scott, Rodney J. ;

Thomas, Huw J. W. ;

Vasen, Hans F. ;

Barker, Gail ;

Crawford, Gillian ;

Elliott, Faye ;

Movahedi, Mohammad ;

Pylvanainen, Kirsi ;

Wijnen, Juul T. ;

Fodde, Riccardo ;

Lynch, Henry T. ;

Mathers, John C. ;

Bishop, D. Timothy .

LANCET, 2011, 378 (9809) :2081-2087

[4] Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial [J].

Cook, Nancy R. ;

Lee, I-Min ;

Zhang, Shumin M. ;

Moorthy, M. Vinayaga ;

Buring, Julie E. .

ANNALS OF INTERNAL MEDICINE, 2013, 159 (02) :77-W32

[5] Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial [J].

Cook, NR ;

Lee, IM ;

Gaziano, JM ;

Gordon, D ;

Ridker, PM ;

Manson, JE ;

Hennekens, CH ;

Buring, JE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01) :47-55

[6] Statins and cancer risk - A meta-analysis [J].

Dale, KM ;

Coleman, CI ;

Henyan, NN ;

Kluger, J ;

White, CM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :74-80

[7]

Emberson JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029849, 10.1016/S0140-6736(12)60367-5]

[8] Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes [J].

Levesque, Linda E. ;

Hanley, James A. ;

Kezouh, Abbas ;

Suissa, Samy .

BRITISH MEDICAL JOURNAL, 2010, 340 :907-911

[9] Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials [J].

Rothwell, Peter M. ;

Wilson, Michelle ;

Price, Jacqueline F. ;

Belch, Jill F. F. ;

Meade, Tom W. ;

Mehta, Ziyah .

LANCET, 2012, 379 (9826) :1591-1601

[10] Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials [J].

Rothwell, Peter M. ;

Price, Jacqueline F. ;

Fowkes, F. Gerald R. ;

Zanchetti, Alberto ;

Roncaglioni, Maria Carla ;

Tognoni, Gianni ;

Lee, Robert ;

Belch, Jill F. F. ;

Wilson, Michelle ;

Mehta, Ziyah ;

Meade, Tom W. .

LANCET, 2012, 379 (9826) :1602-1612

← 1 2 →